FDA Approval for Methadone Hydrochloride by Sun Pharma
The FDA has approved the supplemental application ANDA208305 for Methadone Hydrochloride submitted by Sun Pharma.
Published: June 24, 2026
Updated: June 24, 2026
Author: Humanexa Intelligence
Therapeutic area: Pain Management / Opioid
Company: Sun Pharma
Asset: FDA
Regulatory TimelineREG
Fast Track
Breakthrough
Priority Review
PDUFA
Approval
Company
Sun Pharma
Asset
Signal assessment
Signal strength
high
Confidence level
moderate
Signalhigh
Confidencemoderate
Why it matters
The FDA's approval of Methadone Hydrochloride by Sun Pharma is significant as it strengthens their competitive position in the opioid pain management market. This development necessitates close monitoring of market dynamics and potential competitive responses.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor for market launch details and any competitive responses from other opioid manufacturers.
Related companies & assets
Companies
Sources & Humanexa intelligence
Related Humanexa pages
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.